Source: Eur Respir J 2010; 35: 475-476
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Sester M, Giehl C, Sester U, Meyerhans A.. Management of tuberculosis in HIV infection: where T-cells matter. Eur Respir J 2010; 35: 475-476

Member's Comments

No comment yet.

Related content which might interest you: Clinical management of tuberculosis and HIV-1 co-infection Source: Eur Respir J 2010; 36: 1460-1481 Year: 2010 Combined phenotypical and functional analysis of M. tuberculosis specific immunity for diagnosing active infection and risk assessment in latently infected individuals Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Functional and memory status of M. tuberculosis specific T-cells in HIV-infected patients naïve to antiretroviral treatment Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 The cases of active tuberculosis among persons with latent tuberculosis infection residing in the disease hot spots Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015 Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Monitoring latent tuberculosis infection diagnosis and management in the Netherlands Source: Eur Respir J 2016; 47:1492-1501 Year: 2016 Recurrent tuberculosis among HIV infected persons in Singapore Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011 Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Diagnosis of latent tuberculosis infection Source: ERS Live 2007 Year: 2007 The tuberculosis in patients with HIV and AIDS Source: Eur Respir J 2007; 30: Suppl. 51, 656s Year: 2007 Tuberculosis (TB) detection with HIV infected patients Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Verification of pulmonary tuberculosis in HIV-infected patients with low CD4 Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 CD4+ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infection Source: Eur Respir J 2001; 18: Suppl. 33, 479s Year: 2001 Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Characterization of the HBHA response in TB patients with or without HIV infection. Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Mycobacterium tuberculosis bacteremia in reactivation tuberculosis patients without human immunodeficiency virus infection Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014